Market
Health & bioClear all
Lanes are never summed. Equity is Form D filings and matched press rounds; awards and exits will have their own sources.
Health & bio: subsectors
6 subsectors, sized by amount sold · 90 days to 2026-10-04 · as of 2026-10-0416 rounds not yet in a sector
16 rounds not yet in a sector
- ▲ Rising
- Steady
- Leaning (80%)
- ▼ Falling
- Quiet
Coloured by subsector state, 28 days to 2026-10-03 vs prior 28; shaded when the change is clear at 90% confidence, palest when only at 80%.
Equity · amount sold
Capital by week
Dollars sold per filing week, round count under each bar · 4 weeks to 2026-10-04 · as of 2026-10-04Stage mix
Inferred stage · 90 days to 2026-10-04 · as of 2026-10-04- Pre-seed123 roundsPre-seed rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $157MAmount sold in original Pre-seed filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Seed383 roundsSeed rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $1.2BAmount sold in original Seed filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series A287 roundsSeries A rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $3.7BAmount sold in original Series A filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series B88 roundsSeries B rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $3.5BAmount sold in original Series B filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series C+84 roundsSeries C+ rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $28.8BAmount sold in original Series C+ filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Stage not inferred7 roundsStage not inferred rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $1.0BAmount sold in original Stage not inferred filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
Bar length is each stage’s share of the window’s rounds. Dollars of original filings only: an amendment’s restated amount counts in the map, not here. Stage is inferred from the amount sold, never stated on Form D; a stage named in a press release wins.
Where it landed
Which states the money was raised from, by the company's HQ · 90 days to 2026-10-04 · as of 2026-10-04- $0+
- $353M+
- $1.4B+
- $3.2B+
- $5.7B+
Mega-rounds shown separately (see the band above)
Rounds
Newest first · every row traces to a Form D on EDGAR or a matched press release · as of 2026-10-04| Company | Sector | Stage | Sold of offered | Filed | HQ | Exemption | Open roles | Hiring | Flags | |
|---|---|---|---|---|---|---|---|---|---|---|
| AClarity GenomicsQuiet$4.6M of $4.6M · Seed · Health & bio · 506(b) · Morrisville, NC · 2026-09-02 | AClarity Genomics | Health & bio | Seed | $4.6M of $4.6MAmount sold of the amount offered on the filing of 2026-09-02 · as of 2026-10-04How this is computed → | 2026-09-02 | Morrisville, NC | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| OrthobondQuiet$8.3M of $10.0M · Series A · Health & bio · 506(b) · Monmouth Junction, NJ · 2026-09-01 | Orthobond | Health & bio | Series A | $8.3M of $10.0MAmount sold of the amount offered on the filing of 2026-09-01 · as of 2026-10-04How this is computed → | 2026-09-01 | Monmouth Junction, NJ | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Winter InnovationsQuiet$1.3M of $2.0M · Pre-seed · Health & bio · 506(b) · Knoxville, TN · 2026-09-01 | Winter Innovations | Health & bio | Pre-seed | $1.3M of $2.0MAmount sold of the amount offered on the filing of 2026-09-01 · as of 2026-10-04How this is computed → | 2026-09-01 | Knoxville, TN | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Plowshare TherapiesQuiet$6.7M of $6.7M · Series A · Health & bio · 506(b) · Lancaster, PA · 2026-08-31 | Plowshare Therapies | Health & bio | Series A | $6.7M of $6.7MAmount sold of the amount offered on the filing of 2026-08-31 · as of 2026-10-04How this is computed → | 2026-08-31 | Lancaster, PA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Transform9Hiring actively$5.3M of $5.8M · Seed · Health & bio · 506(b) · Birmingham, AL · 2026-08-31AI-native | Transform9AI-native | Health & bio | Seed | $5.3M of $5.8MAmount sold of the amount offered on the filing of 2026-08-31 · as of 2026-10-04How this is computed → | 2026-08-31 | Birmingham, AL | 506(b) | 9The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | AI-native |
| Halia TherapeuticsQuiet$3.5M of $20.0M · Seed · Health & bio · 506(b) · Lehi, UT · 2026-08-31 | Halia Therapeutics | Health & bio | Seed | $3.5M of $20.0MAmount sold of the amount offered on the filing of 2026-08-31 · as of 2026-10-04How this is computed → | 2026-08-31 | Lehi, UT | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| DalCor PharmaceuticalsQuiet$7.0M of $7.0M · Series A · Health & bio · 506(b) · Sarasota, FL · 2026-08-28 | DalCor Pharmaceuticals | Health & bio | Series A | $7.0M of $7.0MAmount sold of the amount offered on the filing of 2026-08-28 · as of 2026-10-04How this is computed → | 2026-08-28 | Sarasota, FL | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| AEGLE TherapeuticsQuiet$2.3M of $2.3M · Seed · Health & bio · 506(b) · Woburn, MA · 2026-08-28 | AEGLE Therapeutics | Health & bio | Seed | $2.3M of $2.3MAmount sold of the amount offered on the filing of 2026-08-28 · as of 2026-10-04How this is computed → | 2026-08-28 | Woburn, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Noveome BiotherapeuticsQuiet$6.8M of $15.0M · Series A · Health & bio · 506(b) · Pittsburgh, PA · 2026-08-27 | Noveome Biotherapeutics | Health & bio | Series A | $6.8M of $15.0MAmount sold of the amount offered on the filing of 2026-08-27 · as of 2026-10-04How this is computed → | 2026-08-27 | Pittsburgh, PA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Nexus BedsideQuiet$6.3M of $6.3M · Series A · Health & bio · 506(b) · Boca Raton, FL · 2026-08-27 | Nexus Bedside | Health & bio | Series A | $6.3M of $6.3MAmount sold of the amount offered on the filing of 2026-08-27 · as of 2026-10-04How this is computed → | 2026-08-27 | Boca Raton, FL | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Nexus Bedside: $2.6M of $2.6M · Seed · Health & bio · 506(b) · Boca Raton, FL · 2026-08-27 | Nexus Bedside | Health & bio | Seed | $2.6M of $2.6MAmount sold of the amount offered on the filing of 2026-08-27 · as of 2026-10-04How this is computed → | 2026-08-27 | Boca Raton, FL | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Platform Therapeutics (PTX)Quiet$1.8M of $4.0M · Seed · Health & bio · 506(b) · Andover, MA · 2026-08-27 | Platform Therapeutics (PTX) | Health & bio | Seed | $1.8M of $4.0MAmount sold of the amount offered on the filing of 2026-08-27 · as of 2026-10-04How this is computed → | 2026-08-27 | Andover, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| FluidForm BioQuiet$1.7M of $3.0M · Seed · Health & bio · 506(b) · Waltham, MA · 2026-08-27 | FluidForm Bio | Health & bio | Seed | $1.7M of $3.0MAmount sold of the amount offered on the filing of 2026-08-27 · as of 2026-10-04How this is computed → | 2026-08-27 | Waltham, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Epicrispr BiotechnologiesQuiet$177M of $213M · Series C+ · Health & bio · 506(b) · South San Francisco, CA · 2026-08-26 | Epicrispr Biotechnologies | Health & bio | Series C+ | $177M of $213MAmount sold of the amount offered on the filing of 2026-08-26 · as of 2026-10-04How this is computed → | 2026-08-26 | South San Francisco, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Codebreaker Tx, Inc.Quiet$5.9M of $7.4M · Seed · Health & bio · 506(b) · Boulder, CO · 2026-08-26 | Codebreaker Tx, Inc. | Health & bio | Seed | $5.9M of $7.4MAmount sold of the amount offered on the filing of 2026-08-26 · as of 2026-10-04How this is computed → | 2026-08-26 | Boulder, CO | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| XiltriX North AmericaQuiet$3.0M of $3.0M · Seed · Health & bio · 506(b) · San Diego, CA · 2026-08-26 | XiltriX North America | Health & bio | Seed | $3.0M of $3.0MAmount sold of the amount offered on the filing of 2026-08-26 · as of 2026-10-04How this is computed → | 2026-08-26 | San Diego, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| ProEncia BiotechnologyQuiet$1.5M of $2.0M · Seed · Health & bio · 506(b) · Woodbury, MN · 2026-08-26 | ProEncia Biotechnology | Health & bio | Seed | $1.5M of $2.0MAmount sold of the amount offered on the filing of 2026-08-26 · as of 2026-10-04How this is computed → | 2026-08-26 | Woodbury, MN | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| LeviantQuiet$13.0M of $15.8M · Series A · Health & bio · 506(b) · Hawthorne, NY · 2026-08-25 | Leviant | Health & bio | Series A | $13.0M of $15.8MAmount sold of the amount offered on the filing of 2026-08-25 · as of 2026-10-04How this is computed → | 2026-08-25 | Hawthorne, NY | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Axiom TherapeuticsQuiet$12.3M of $12.3M · Series A · Health & bio · 506(b) · Claymont, DE · 2026-08-25AI-native | Axiom TherapeuticsAI-native | Health & bio | Series A | $12.3M of $12.3MAmount sold of the amount offered on the filing of 2026-08-25 · as of 2026-10-04How this is computed → | 2026-08-25 | Claymont, DE | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | AI-native |
| Serif HealthHiring actively$5.6M of $5.6M · Seed · Health & bio · 506(b) · San Francisco, CA · 2026-08-25 | Serif Health | Health & bio | Seed | $5.6M of $5.6MAmount sold of the amount offered on the filing of 2026-08-25 · as of 2026-10-04How this is computed → | 2026-08-25 | San Francisco, CA | 506(b) | 1The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| Gradient HealthHiring actively$3.0M of $3.0M · Seed · Health & bio · 506(b) · Durham, NC · 2026-08-25 | Gradient Health | Health & bio | Seed | $3.0M of $3.0MAmount sold of the amount offered on the filing of 2026-08-25 · as of 2026-10-04How this is computed → | 2026-08-25 | Durham, NC | 506(b) | 1The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| CardiosenseHiring actively$26.1M of $42.0M · Series B · Health & bio · 506(b) · Chicago, IL · 2026-08-24 | Cardiosense | Health & bio | Series B | $26.1M of $42.0MAmount sold of the amount offered on the filing of 2026-08-24 · as of 2026-10-04How this is computed → | 2026-08-24 | Chicago, IL | 506(b) | 1The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| DozeeQuiet$10.0M of $10.0M · Series A · Health & bio · 506(b) · Houston, TX · 2026-08-24 | Dozee | Health & bio | Series A | $10.0M of $10.0MAmount sold of the amount offered on the filing of 2026-08-24 · as of 2026-10-04How this is computed → | 2026-08-24 | Houston, TX | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Unravel BiosciencesQuiet$4.1M of $4.5M · Seed · Health & bio · 506(b) · Medford, MA · 2026-08-24AI-native | Unravel BiosciencesAI-native | Health & bio | Seed | $4.1M of $4.5MAmount sold of the amount offered on the filing of 2026-08-24 · as of 2026-10-04How this is computed → | 2026-08-24 | Medford, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | AI-native |
| FSH TechnologiesQuiet$24.1M of $24.1M · Series A · Health & bio · 506(b) · Philadelphia, PA · 2026-08-21 | FSH Technologies | Health & bio | Series A | $24.1M of $24.1MAmount sold of the amount offered on the filing of 2026-08-21 · as of 2026-10-04How this is computed → | 2026-08-21 | Philadelphia, PA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Outer BioQuiet$23.3M of $23.3M · Series A · Health & bio · 506(b) · Malden, MA · 2026-08-21 | Outer Bio | Health & bio | Series A | $23.3M of $23.3MAmount sold of the amount offered on the filing of 2026-08-21 · as of 2026-10-04How this is computed → | 2026-08-21 | Malden, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Samothrace Medical InnovationsQuiet$5.2M of $8.6M · Seed · Health & bio · 506(b) · Daniel Island, SC · 2026-08-21 | Samothrace Medical Innovations | Health & bio | Seed | $5.2M of $8.6MAmount sold of the amount offered on the filing of 2026-08-21 · as of 2026-10-04How this is computed → | 2026-08-21 | Daniel Island, SC | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| EXUMA BiotechQuiet$70.0M of $70.0M · Series C+ · Health & bio · 506(b) · West Palm Beach, FL · 2026-08-20 | EXUMA Biotech | Health & bio | Series C+ | $70.0M of $70.0MAmount sold of the amount offered on the filing of 2026-08-20 · as of 2026-10-04How this is computed → | 2026-08-20 | West Palm Beach, FL | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Oxbridge HealthQuiet$38.5M of $45.0M · Series B · Health & bio · 506(b) · Norwalk, CT · 2026-08-20 | Oxbridge Health | Health & bio | Series B | $38.5M of $45.0MAmount sold of the amount offered on the filing of 2026-08-20 · as of 2026-10-04How this is computed → | 2026-08-20 | Norwalk, CT | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| AmplificaQuiet$25.0M of $25.0M · Series B · Health & bio · 506(b) · San Diego, CA · 2026-08-20 | Amplifica | Health & bio | Series B | $25.0M of $25.0MAmount sold of the amount offered on the filing of 2026-08-20 · as of 2026-10-04How this is computed → | 2026-08-20 | San Diego, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Sentonix, Inc.Quiet$12.7M of $21.2M · Series A · Health & bio · 506(b) · Arlington, MA · 2026-08-20 | Sentonix, Inc. | Health & bio | Series A | $12.7M of $21.2MAmount sold of the amount offered on the filing of 2026-08-20 · as of 2026-10-04How this is computed → | 2026-08-20 | Arlington, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| ArthromedaQuiet$8.6M of $10.9M · Series A · Health & bio · 506(b) · Lowell, MA · 2026-08-20 | Arthromeda | Health & bio | Series A | $8.6M of $10.9MAmount sold of the amount offered on the filing of 2026-08-20 · as of 2026-10-04How this is computed → | 2026-08-20 | Lowell, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Deon HealthQuiet$8.0M of $10.0M · Series A · Health & bio · 506(b) · Port Huron, MI · 2026-08-20 | Deon Health | Health & bio | Series A | $8.0M of $10.0MAmount sold of the amount offered on the filing of 2026-08-20 · as of 2026-10-04How this is computed → | 2026-08-20 | Port Huron, MI | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Latitude HealthHiring actively$4.0M of $4.0M · Seed · Health & bio · 506(b) · San Francisco, CA · 2026-08-20AI-native | Latitude HealthAI-native | Health & bio | Seed | $4.0M of $4.0MAmount sold of the amount offered on the filing of 2026-08-20 · as of 2026-10-04How this is computed → | 2026-08-20 | San Francisco, CA | 506(b) | 1The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | AI-native |
| Latitude Health: $2.0M of $3.0M · Seed · Health & bio · 506(b) · San Francisco, CA · 2026-08-07AI-native | Latitude HealthAI-native | Health & bio | Seed | $2.0M of $3.0MAmount sold of the amount offered on the filing of 2026-08-07 · as of 2026-10-04How this is computed → | 2026-08-07 | San Francisco, CA | 506(b) | 1The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | AI-native |
| NovirHiring actively$3.1M of $4.0M · Seed · Health & bio · 506(b) · Milwaukee, WI · 2026-08-20 | Novir | Health & bio | Seed | $3.1M of $4.0MAmount sold of the amount offered on the filing of 2026-08-20 · as of 2026-10-04How this is computed → | 2026-08-20 | Milwaukee, WI | 506(b) | 17The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| LifeCyte InnovationsQuiet$1.0M of $5.0M · Pre-seed · Health & bio · 506(b) · Greensboro, GA · 2026-08-20 | LifeCyte Innovations | Health & bio | Pre-seed | $1.0M of $5.0MAmount sold of the amount offered on the filing of 2026-08-20 · as of 2026-10-04How this is computed → | 2026-08-20 | Greensboro, GA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| K HealthHiring actively$58.9M of $68.9M · Series B · Health & bio · 506(b) · New York, NY · 2026-08-19AI-native | K HealthAI-native | Health & bio | Series B | $58.9M of $68.9MAmount sold of the amount offered on the filing of 2026-08-19 · as of 2026-10-04How this is computed → | 2026-08-19 | New York, NY | 506(b) | 19The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | AI-native |
| MaxQ MedicalQuiet$31.5M of $31.5M · Series B · Health & bio · 506(b), 4(a)(5) · Sunnyvale, CA · 2026-08-19 | MaxQ Medical | Health & bio | Series B | $31.5M of $31.5MAmount sold of the amount offered on the filing of 2026-08-19 · as of 2026-10-04How this is computed → | 2026-08-19 | Sunnyvale, CA | 506(b), 4(a)(5) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| ApollomicsQuiet$10.0M of $10.0M · Series A · Health & bio · 506(b) · Foster City, CA · 2026-08-19 | Apollomics | Health & bio | Series A | $10.0M of $10.0MAmount sold of the amount offered on the filing of 2026-08-19 · as of 2026-10-04How this is computed → | 2026-08-19 | Foster City, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Gamow LabsHiring actively$3.5M of $3.5M · Seed · Health & bio · 506(b) · Denver, CO · 2026-08-19AI-native | Gamow LabsAI-native | Health & bio | Seed | $3.5M of $3.5MAmount sold of the amount offered on the filing of 2026-08-19 · as of 2026-10-04How this is computed → | 2026-08-19 | Denver, CO | 506(b) | 1The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | AI-native |
| AER TherapeuticsQuiet$3.0M of $3.0M · Seed · Health & bio · 506(b) · Research Triangle Park, NC · 2026-08-19 | AER Therapeutics | Health & bio | Seed | $3.0M of $3.0MAmount sold of the amount offered on the filing of 2026-08-19 · as of 2026-10-04How this is computed → | 2026-08-19 | Research Triangle Park, NC | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet |